SIMAGEC acquired by STERIMED
Context
The acquisition of Simagec by Sterimed is a strategic move to expand Sterimed's service offering to medical device manufacturers and pharmaceutical companies. The deal complements Sterimed's existing operations and enables the company to further strengthen its position in the medical packaging market. Simagec's expertise in rigid and flexible packaging solutions, contract packaging, and validation services will enhance Sterimed's capabilities and provide a more comprehensive range of services to its customers. The acquisition is also expected to accelerate Sterimed's strategic growth in the pharmaceutical industry, where Simagec has established a strong presence. The deal is a testament to Sterimed's commitment to innovation and growth, and is expected to drive long-term value creation for the company's shareholders. With the integration of Simagec, Sterimed will be able to leverage the combined expertise and capabilities of both companies to drive growth and expansion in the medical packaging market. The acquisition is also expected to provide new opportunities for Simagec's employees and customers, as part of a larger and more diversified company.
SIMAGEC, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Industry & Manufacturing sector (11.6x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Industry & Manufacturing market trends
Target
Simagec is a French company specializing in medical packaging solutions for the pharmaceutical industry and medical device manufacturers. With a strong expertise in rigid packaging for the medical device industry, the company has expanded its operations to provide a comprehensive range of products and services, including rigid and flexible medical packaging solutions, contract packaging for medical devices, and validation and qualification services. Simagec has also developed a business in the pharmaceutical industry, packaging disinfectant liquids in aseptic clean rooms through its subsidiary Sima Pharma. Additionally, the company designs and manufactures machinery and equipment for its own needs and for its customers in the medical sector through its engineering department, Sima Meca. With 120 employees, Simagec is a key player in the French medical packaging market, offering high-quality services to its customers. The company's expertise and capabilities make it an attractive partner for medical device manufacturers and pharmaceutical companies looking for reliable and innovative packaging solutions.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in Industry & Manufacturing
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 06/2026 | HOWDENS | DIY KITCHENS | UNITED KINGDOM | Chemicals & Materials | Howdens has agreed to acquire DIY Kitchens, a UK-based online kitchen manufacturer and retailer, in a transaction designed to broaden its route-to-market strategy and expand its reach beyond its traditional trade customer base. The acquisition provides direct exposure to non-trade consumers who prefer to design, configure and purchase kitchens independently through a digital platform. The transaction is based on strategic complementarity rather than commercial integration. Howdens will continue to focus exclusively on trade professionals through its nationwide depot network, while DIY Kitchens will remain an online-only business serving end consumers |
| 06/2026 | JOHNSON MATTHEY | CORMETECH | UNITED STATES | Chemicals & Materials | Johnson Matthey acquires Cormetech, a US-based specialist in SCR catalysts used for emissions control in power generation and industrial applications. The transaction strengthens JM’s Clean Air Solutions business, which focuses on pollution abatement technologies for stationary engines, gas turbines and coal-fired power plants. The acquisition is designed to enhance JM’s positioning in a structurally growing emissions control market, underpinned by stricter environmental regulation and rising electricity demand driven by data centre expansion and distributed power generation |
| 05/2026 | SAICA GROUP | THIMM GROUP | GERMANY | Chemicals & Materials | Saica Group has announced a definitive agreement to acquire 100% of Thimm Group, a premier European provider of sustainable packaging and display solutions. This transaction represents a landmark corporate buyout within the European paper and packaging sector, uniting two industrial giants with a deeply institutionalized history of partnership, including a strategic sales alliance and an active joint venture in Poland. The acquisition thesis represents a major, transformational consolidation play designed to capture absolute market leadership within the Western and Eastern European packaging landscapes |
| 05/2026 | COSMOGEN | ASQUAN | CHINA | Chemicals & Materials | This transaction represents Cosmogen's first external growth initiative since its spin-off and is a transformative step to double its operational scale. Driven by its controlling shareholder, Weinberg Capital Partners, the acquisition aims to create a new global reference in the premium beauty packaging market, the Cosmogen & Asquan Group. The strategic rationale is founded on the strong complementarities between the two entities. Cosmogen contributes its deep expertise in patented, technical applicators and its established relationships with major European beauty conglomerates |
| 04/2026 | INTERNATIONAL PAPER COMPANY | NORPAC | UNITED STATES | Chemicals & Materials | The group has finalized an agreement to acquire the target from One Rock Capital Partners, a maneuver designed to fundamentally expand its manufacturing capabilities in the growing West Coast region. The strategic rationale for this transaction centers on a "network-flexibility" play, merging the target's industry-leading technical operational depth in recycled fiber milling with the group’s established global distribution and containerboard framework. This structural alignment provides the organization with the scientific talent and high-performance hardware (specifically the target's three specialized machines) required to address the increasing demand for lightweight, high-performance recycled packaging |
| 04/2026 | LIFCO | METALLTECH | ITALY | Chemicals & Materials | The Swedish investment holding has signed a definitive agreement to acquire a majority interest in the target, marking its first transaction in the Italian market for the 2026 fiscal year. This operation follows a high-velocity acquisition pipeline aimed at consolidating a portfolio of high-performing "Made in Italy" industrial champions. The strategic rationale for the move centers on the integration of a highly profitable niche specialist into the group’s multidisciplinary industrial business area |
| 02/2026 | SAGARD | ESSENCES & PARFUMS | FRANCE | Chemicals & Materials | Sagard acquired a majority stake in Essences & Parfums from Trajan, which exited the business alongside minority investors Bpifrance, Smalt Capital, and the original founders. The transaction, completed following a swift three-month competitive process managed by an investment bank, saw strong interest from both financial sponsors and industrial players. The current management team, led by President Samuel Desprets, significantly reinvested in the deal. The transaction was financed via a unitranche debt facility provided by Eurazeo |
| 02/2026 | CVC | DSM-FIRMENICH ANH (ANIMAL NUTRITION & HEALTH) | SWITZERLAND | Chemicals & Materials | DSM-Firmenich has agreed to sell a majority interest in its Animal Nutrition and Health (ANH) business to CVC Capital Partners. Under the terms of the agreement, DSM-Firmenich will retain a 20% minority stake to benefit from future upside. The transaction structure involves a combination of cash proceeds (~EUR600 million) and the transfer of debt/liabilities (~EUR500 million) to the new standalone entity. Additionally, the deal includes an earn-out component based on future performance. Post-closing, the business will be operationally split into two separate entities: "Solutions Company" and "Essential Products Company," both headquartered in Switzerland |
| 02/2026 | ONE EQUITY PARTNERS | GIOVANNI BOZZETTO | ITALY | Chemicals & Materials | One Equity Partners acquired a majority stake in Giovanni Bozzetto from the Canadian diversified holding company Aimia Inc. and Paladin Private Equity. The transaction followed Aimia's brief ownership period (since May 2023), during which the group expanded into Central America via the acquisition of StarChem. OEP plans to leverage its industrial expertise to accelerate Bozzetto's international expansion, particularly in the Americas and Asia, while doubling down on "Green Chemistry" innovations |
| 02/2026 | MEARTHANE PRODUCTS CORPORATION | AXILLON AEROSPACE - POLYURETHANE | UNITED STATES | Chemicals & Materials | This corporate carve-out transaction marks the full acquisition of Axillon Aerospace’s industrial composites business by Mearthane Products Corporation, representing the platform's latest programmatic transaction over a multi-year period and accelerating its long-term capital deployment strategy. By acquiring an active, fully staffed facility in Cincinnati, Mearthane bypasses greenfield capital expenditure timelines to achieve immediate capacity expansion, alleviating internal manufacturing bottlenecks while securing operational continuity under the leadership of senior production manager Kevin Perkins |
REFERENCES
Revenue range: 5M - 25M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SIMAGEC by STERIMED are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Target: simagec
Acquirer: sterimed